This webinar, led by James Britton, focuses on the role of dedicated Barrett’s Oesophagus Services and how to detect dysplasia/early cancer. The webinar also covers what future surveillance may look like and includes updates from the BOSS Trial.
Suitable for: Gastroenterologists, Surgeons, Clinical Endoscopists, Nurse Endoscopists, Registrars, any staff conducting OGD’s within their clinical practice.